EU and AstraZeneca fail to end dispute over delayed vaccine deliveries, after another meeting last night

The company's warning of a shortage of supply - meaning Ireland will only get half of the 600,000 doses due by the end of March.
AstraZeneca blames production issues at European plants, but the EU says the jabs must be delivered as scheduled.
Former director-general of the HSE, Tony O'Brien, says a solution needs to be found:
"Ultimately the dispute does have to be resolved. It's very high stakes, but it's important that as the discussions progress that people don't allow more heat and light to enter into the process on the one hand, obviously, the needs to be satisfied that it's being treated fairly and on the other hand, the realistic challenges of producing this vaccine need to be taken into account."